Events2Join

PSA screening reduced deaths can miss aggressive cancer


PSA screening reduced deaths can miss aggressive cancer

Behind the headlines: PSA screening reduces prostate cancer deaths but can miss aggressive cancer. New results confirm that screening for ...

Risk of prostate cancer death following a low prostate-specific ...

No men aged ≥ 65yrs with PSA ≤ 0.5ng/ml died from prostate cancer within 15yrs (95% CI: 0.00%−0.32%), and their 10-year incidence of aggressive disease was low ...

Can prostate cancer screening with the PSA test help to save lives?

The study found that a single invitation to a PSA blood test for men without symptoms had little impact on reducing prostate cancer deaths.

Prostate Cancer Screening - StatPearls - NCBI Bookshelf

Prostate cancer remains the second leading cause of cancer death in men, and worldwide incidence is increasing. Stopping PSA screenings will not reduce prostate ...

Prostate-Specific Antigen Screening and Prostate Cancer Mortality ...

Findings In this cohort study of 45 834 US veterans, PSA screening was associated with decreased risk of prostate cancer–specific mortality ( ...

Screening with a PSA test has a small impact | EurekAlert!

The largest study to date investigating a single invitation to a PSA blood test to screen for prostate cancer has found it had a small impact on reducing ...

Less Prostate Cancer Screening Reduces Overdiagnosis but May ...

Less Prostate Cancer Screening Reduces Overdiagnosis but May Miss Aggressive Cases ... Over the past 15 years, public health authorities have ...

Risk of Prostate Cancer–related Death Following a Low PSA Level ...

Compared with white men, black men with PSA ≤ 1 ng/mL had higher 10-year rates of aggressive disease (1.6% vs. 0.4%; P < 0.01). Five-year screening intervals ...

Access to PSA Testing and Mortality Among Men With Prostate Cancer

We hypothesized that men living in counties with a higher prevalence of PSA screening would be more likely to be screened, leading to a lower ...

Solo PSA test does not lower mortality | Nature Reviews Urology

Use of a single PSA screening intervention does not reduce prostate cancer mortality after a median follow-up duration of 10 years, but does increase the ...

Reduced PSA Prostate Cancer Screening: Life-threatening ...

Although the recommendation has reduced surgical treatment for low-grade cancers, the study has shown that reduced screening can lead to an ...

UK study finds screening with a PSA test in prostate cancer can lead ...

However, research has shown that the PSA test can sometimes increase the detection of low-risk prostate cancers and miss some high-risk cases.

Reconsidering Prostate Cancer Mortality — The Future of PSA ...

PSA screening caused an absolute decrease in metastatic incidence of 17 per 100,000 men — a reduction that exceeds the absolute decrease in ...

Prostate cancer screening: Should you get a PSA test? - Mayo Clinic

Cancer screening tests — including the prostate-specific antigen (PSA) test to look for signs of prostate cancer — can be a good idea ...

April: prostate-cancer | News and features | University of Bristol

... reducing deaths, but also led to overdiagnosis and missed early detection of some aggressive cancers ... PSA screening, can be viewed here ...

Targeted screening for prostate cancer could prevent one in six deaths

A national screening programme targeted at men who are genetically pre-disposed to prostate cancer, and involving a blood test and MRI scan before an invasive ...

Prostate Cancer: Screening - U.S. Preventive Services Task Force

Screening offers a small potential benefit of reducing the chance of death from prostate cancer in some men. However, many men will experience ...

Prostate Cancer: Early Detection Guideline

In the US, early detection is driven by prostate specific antigen (PSA)-based screening followed by prostate biopsy for diagnostic confirmation. While the ...

Screening and Prostate-Cancer Mortality in a Randomized ...

PSA-based screening reduced the rate of death from prostate cancer by 20% but was associated with a high risk of overdiagnosis.

Specific Antigen (PSA) Test - Key Messages for Healthcare Providers

It can also miss some cancers in men who do have ... This recommendation places a relatively low value on a small potential absolute decrease in prostate cancer ...